The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine

BACKGROUND: HBV is still a worldwide health problem. Annually about 0.5-1.2 million patients die of HBV-related diseases such as liver cirrhosis and hepatocellular carcinoma. Lamivudine (LAM) is the first nucleoside analog used in the treatment of chronic hepatitis B. As LAM has been clinically used...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Jie, Xie, Wen, Wang, Qi, Li, Yue, Feng, Xing, Cheng, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212783/
https://www.ncbi.nlm.nih.gov/pubmed/22087161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212783/
https://www.ncbi.nlm.nih.gov/pubmed/22087161

Ejemplares similares